APT Chart, page-1637

First 1637 Last

Share
Profile

Follow
Trevor2017

1,032 Posts.

154

19/05/20

16:35

Post #: 44707678
Share

Originally posted by Trevor2017: ↑

Normally I wouldn't address your points but one element that interested me is that to understand the popularity of BNPL, one needs to put it against credit cards.

As you pointed out, cards make revenue by charging interest rates. For this reason cards issuers won't stop you from getting into bigger debt as long as it's within limit. BNPL makes revenue from merchants and the late fee is generally not enough to cover average balance and so it has the incentive to stop people from getting into debt. Young generation prefers this as a budgeting tool over cards.

Another aspect is cards were designed few decades ago where paperwork was still prevalent. It wasn't possible for banks to lend out a small amount of $100 in large volume so it's sensible to seek customers credit history and if acceptable, give them a line of credit with limit. These days we all have mobiles and a large amount of data can be entered, stored and fetched in a split of a second. The best way for small consumer lending is to lend them a small amount and check their credit through 'action', i.e. whether they would pay back. The convenience of using BNPL is way superior than credit cards for the mobile-and-social-media -addicted generations.

It's also funny that you complained that BNPL causes financial stress for customers with an average balance of $150 while $2000 interests from credit cards is 'not a great deal of money'....

Expand

my bad - last sentence wasn't right as I misread the message.

APT Price at posting: $42.00 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 3,033 more messages in this thread...

First 1637 Last

Add APT (ASX) to my watchlist

APT Chart, page-1637

Top Stories

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News